Fujimori, M., Sugenoya, A., Kobayashi, S., Masuda, H., Komatsu, M., Takahashi, S., Shimizu, T., Tsuchiya, S., Iida, F. (1989) Local immunotherapy for breast cancer: case with advanced breast cancer improved by combined local injection therapy with OK-432 and rIL-2. Japanese Journal of Cancer Chemotherapy 16: 2760–2763.
Fujioka, T., Ishikura, K., Tanji, S., Okamoto, T., Koike, H., Aoki, H., Ohhori, T., Kubo, T. (1990) Combined effects of intraperitoneal administration of recombinant interleukin-2 and Streptococcal preparation OK-432 in murine tumours. International Journal of Immunopharmacology 12: 419–426.
Hirakawa, H., Akimoto, M., Matano, S., Abe, M., Mori, S. (1989) A case with multiple liver metastasis from breast cancer successfully treated by local injection of OK-432 (400KE) and trans-arterial infusion of rIL-2. Biotherapy 3: 742–745.
Ichimura, O., Suzuki, S., Saito, M. (1985). Augmentation of interleukin 1 and interleukin 2 production by OK-432. International Journal of Immunopharmacology 7: 263–268.
Ikeda, M., Tsuru, S., Shinomiya, N., Taniguchi, M., Fujisawa, T., Zinnaka, Y. (1985) Activation of peritoneal macrophages induced by OK-432. Journal of National Defense Medical College 10: 115–119.
Ishii, Y., Yamaoka, H., To, K., Kikuchi, K. (1976) Inhibition of tumour growth in vivo by macrophages from rat treated with a Streptococcal preparation, OK-432. Gann 67: 115–119.
Kitahara, S., Ikeda, M., Tanabe, T., Sakata, J., Inouye, T. (1989) Treatment of head and neck cancer by OK-432 local injection. Therapeutic Research 10: 383–391.
Kokunai, I., Mori, T., Yayoi, E., Matsuura, N., Kamimae, G. (1985) Correlation between anti-tumour effect and delayed hypersensitivity induced by topically applied OK-432 with histological findings. Japanese Journal of Surgery 86: 258–265.
Misaki, T., Watanabe, Y., Iida, Y., Hidaka, A., Kasagi, K., Fukushima, H., Konishi, J. (1992) Recruitment of T lymphocytes and induction of tumour necrosis factor in thyroid cancer by a local immunotherapy. Cancer Immunology Immunotherapy 35: 92–96.
Mizutani, Y., Nio, Y., Yoshida, O. (1991) The Streptococcal preparation OK-432 specificity augments the susceptibility of human urinary bladder tumour cells to autologous peripheral blood lymphocytes. Cancer 69: 2999–3007.
Ogita, S., Tsuto, T., Deguchi, E., Tokiwa, K., Nagashima, M., Iwai, N. (1991) OK-432 therapy for unresectable lymphangiomas in children. Journal of Pediatric Surgery 26: 263–270.
Oshimi, K., Kano, S., Takaku, F., Okaumura, K. (1980a) Augmentation of mouse natural killer cell activity by a Streptococcal preparation, OK-432. Journal of the National Cancer Institute 65: 1265–1270.
Oshimi, K., Wakasugi, H., Seki, H., Kano, S. (1980b) Streptococcal preparation OK-432 augments cytotoxic activity against an erythroleukemic cell line in humans. Cancer Immunology Immunothreapy 9: 187–192.
PMS report 1989 (no. 2): Pharmaceutical Affairs Bureau, Ministry of Health and Welfare Japan, 1134, December 20, 1989.
Saito, M., Ebina, T., Koi, M. (1982) Introduction of interferon in mice spleen cells by OK-432, a preparation of Streptococcus pyogenes. Cellular Immunology 68: 184–192.
Saito, M., Yamaguchi, T., Ebina, T., Koi, M., Aonuma, E., Usami, H., Ishida, N. (1983) In vitro production of immune interferon (IFNr) by murine spleen cells when different sensitizing antigens are used in vitro. Cellular Immunology 78: 379–386.
Saito, M., Nanjo, M., Aonuma, E., Noda, T., Nakadate, I., Ebina, T., Ishida, N. (1984) Activated macrophages are responsible for the tumour inhibitory effect in mice receiving intravenous injection of OK-432. International Journal of Cancer 33: 271–276.
Saito, M., Nanjo, M., Kataoka, M., Moriya, Y., Sugawara, Y., Yoshida, T., Ishida, N. (1988) Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumour site in mice. Cancer Research 48: 4163–4169.
Uchida, A., Mickshe, M. (1983a) Lysis of fresh human tumour cells by autologous peripheral blood lymphocytes and plural effusion lymphocytes activated by OK 432. Journal of the National Cancer Institute 71: 673–680.
Uchida, A., Mickshe, M. (1983b) Lysis of fresh human tumour cells by autologous large granular lymphocytes from peripheral blood and plural effusions. International Journal of Cancer 32: 37–41.
Wakasugi, H., Kasahara, T., Minato, N., Hamuro, J., Miyata, M., Morioka, Y. (1982) In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-Interferon and Interleukin-2 participation in the stimulation with OK-432. Journal of the National Cancer Institute 69: 807–812.
Yamamoto, A., Nagamuta, M., Usami, H., Sugawara, Y., Watanabe, N., Niitsu, Y., Urushizaki, I. (1986) Release of tumour necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a Streptococcal preparation. Immunopharmacology 11: 79–86.
Yamashita, R., Hirooka, T., Kamimoto, I., Miyauchi, Y. (1986) Prevention of growth of metastasis in rat liver by perioperative immunoactivation. Cancer Research 46: 3138–3141.
Yamaue, H., Tanimura, H., Tsunoda, T., Iwahashi, M., Tani, M., Tamai, M., Noguchi, K., Hotta, T., Arii, K. (1992) Enhancement of tumour cell susceptibility to lymphokineactivated killer cells by treatment with the Streptococcal preparation OK-432. Biotherapy 5: 83–93.